ChromaVision Medical Systems, Inc.
Diagnostics company names Ronald A. Andrews, Jr. CEO
Published in Biotech Law Weekly, August 20th, 2004
Andrews will replace Michael F. Cola, the chairman of the board who has served as ChromaVision interim CEO since February 2004.
Cola said the search process for a new CEO was extensive and was directed by a very specific set of qualifications involving both applicable corporate experience and personal character; he added that Andrews' direct and senior experience in diverse aspects of the diagnostics industry was an important factor as the company is presently embarking on a number of new strategic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2004-08-20)
More Articles from Biotech Law Weekly
- Ablynx
Nanobody drug discovery and development partnership signed - CardioGenesis Corp.
Medicare panel's review of myocardial revascularization complete - Collaborations
Gold Standard, ACP to integrate and market Clinical Pharmacology, PIER Products - Cutting Edge Information
Generic drug sales to exceed $60 billion by 2007 - Exeter Life Sciences
ViaGen parent establishes biotech IP, licensing, and investment division - Genetronics Biomedical Corp.
Tumor-focused biomedical company wins another electroporation patent - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
